Interestingly, the NAM HD treatment induced Nr1h2 expression (encoding LXRβ) (1.7-fold, p ˂ 0.05) without changing the expression of Nr1h3 (encoding LXRα) (Figure S4, panel (a)). The gene discussed is NR1H3; the disease is Huntington disease.